UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 2, 2005

Dynacq Healthcare, Inc.

(Exact name of registrant as specified in its charter)

Delaware	000-21574	76-0375477
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(I.R.S. Employer Identification No.)

10304 Interstate 10 East, Suite 369

Houston, Texas 77029

(Address of principal executive offices and zip code)

(713) 378-2000

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events

On May 2, 2005, Dynacq Healthcare, Inc. (the “Company”) issued a press release announcing that the Nasdaq Stock Market had approved the Company’s application to list its common stock on The Nasdaq SmallCap Market. The Nasdaq Stock Market reserved “DYII” as the trading symbol for the Company’s common stock. The Company’s shares will commence trading on the Nasdaq SmallCap on Tuesday, May 3, 2005. A copy of the press release is attached as an exhibit.

Item 9.01 Financial Statements and Exhibits

(c) Exhibits.

Exhibit Number	Description
Exhibit 99.1	Press Release dated May 2, 2005.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dynacq Healthcare, Inc.
By:	/s/ Philip S. Chan
	Philip S. Chan,
	Chief Financial Officer

Date: May 2, 2005.

Exhibit Index

Exhibit Number	Description
*Exhibit 99.1	Press Release dated May 2, 2005.

* Filed herewith